XML 26 R12.htm IDEA: XBRL DOCUMENT
v3.21.2

Patents and Other Intangible Assets | 9 Months Ended
--- | ---
Sep. 30, 2021
Patents and Other Intangible Assets |
Patents and Other Intangible Assets | Note 4 – Patents and Other Intangible Assets Patents and other intangible assets are summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | December 31,
​ | ​ | 2021 | ​ | 2020
Patents |  | ​ |  |  | ​ |
Patents pending | ​ | $ | 596,000 | ​ | $ | 731,000
Issued patents | ​ |  | 538,000 | ​ |  | 883,000
​ | ​ |  | 1,134,000 | ​ |  | 1,614,000
Trademarks | ​ |  | ​ | ​ |  | ​
Trademarks pending | ​ |  | 1,000 | ​ |  | 105,000
Registered trademarks | ​ |  | 95,000 | ​ |  | 23,000
​ | ​ |  | 96,000 | ​ |  | 128,000
Other | ​ |  | 8,000 | ​ |  | 8,000
​ | ​ |  | 1,238,000 | ​ |  | 1,750,000
Accumulated amortization | ​ |  | (296,000) | ​ |  | (448,000)
​ | ​ | $ | 942,000 | ​ | $ | 1,302,000
​ Future amortization expense associated with issued patents and registered trademarks as of September 30, 2021 is as follows: ​
​ | ​ | ​ | ​
2021 (remaining 3 months) |  | $ | 28,000
2022 | ​ |  | 114,000
2023 | ​ |  | 91,000
2024 | ​ |  | 67,000
2025 | ​ |  | 32,000
Thereafter | ​ | ​ | 6,000
​ | ​ | $ | 338,000
​ During the three months ended September 30, 2021, the Company assessed its patent and trademark assets. The Company also evaluated its strategic approach to the pursuit and protection of its intellectual property. It is the intent of the Company to continue to define the scope of pursuing intellectual property protection to be more aligned with core technology critical to the design of product offerings. ​ The Company identified certain assets where the intellectual property was not directly related to core technology within current products. Based on the results of the assessment, the Company has impaired $200,000 of assets previously classified as pending patent costs and of assets previously classified as pending trademark costs. This non-cash expense is reflected in the current quarter operating results as Research and Development and General and Administrative expenses, respectively. For certain issued patents where the protected intellectual property was not directly aligned with current products, the Company accelerated the amortization by $50,000 to reduce the financial net carrying value of capitalized patent costs and an additional $40,000 in accelerated amortization to align trademark net capitalized costs with trademark registeration dates.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration